A new meta-analysis published in BMC Nephrology reports that there is no significant difference in overall survival between patients undergoing peritoneal dialysis (PD) and those receiving hemodialysis (HD) for end-stage renal disease (ESRD). The study analyzed data from multiple clinical investigations comparing the two dialysis modalities and found that both approaches are equally effective in maintaining patient survival. This suggests that treatment decisions can be tailored based on patient preferences, lifestyle, and clinical suitability rather than concerns about mortality differences.
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!